홈 › 흑색종 › 노스캐롤라이나

노스캐롤라이나의 흑색종 임상 시험

흑색종 관련 연구 32개가 노스캐롤라이나 내 여러 지역에서 참여자를 모집하고 있습니다.

노스캐롤라이나의 도시

공식 연구 텍스트(영어)

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Southeastern Medical Oncology Center-Clinton, Clinton
Southeastern Medical Oncology Center-Goldsboro, Goldsboro
Southeastern Medical Oncology Center-Jacksonville, Jacksonville

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT05136196

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Carolina Cancer Research Center, Wilson

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06270706

IL-17 Blockade to Decrease irAEs (REPLAY)

Duke University Health System, Durham

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT07237594

A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy

Duke University Medical Center, Durham

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT05077137

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Messino Cancer Center, Asheville
Levine Cancer Institute, Charlotte
Novant Health Cancer Institute, Charlotte
외 3개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT06246916

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

AdventHealth Infusion Center Asheville, Asheville
Southeastern Medical Oncology Center-Clinton, Clinton
AdventHealth Infusion Center Haywood, Clyde
외 6개

피험자 모집 중관찰 연구건강한 지원자 환영

40세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05334069

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Atrium Health Stanly/LCI-Albemarle, Albemarle
Cone Health MedCenter Asheboro, Asheboro
Cone Health Cancer Center at Alamance Regional, Burlington
외 21개

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06418204

A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Local Institution - 0100, Durham

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07492680

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill

피험자 모집 중1/2상

18세 ~ 90세 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT05655312

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

Clinical Trial Site, Huntersville

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT07749586

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Duke Cancer Institute, Durham

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT07070232

NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma

Lineberger Comprehensive Cancer Center, Chapel Hill

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07740941

DESTINY-PANTUMOUR04

Research Site, Durham
Research Site, Wilson

피험자 모집 중관찰 연구

18세 ~ 130세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07124000

Pan-tumor MRD Study

Carolina Oncology Specialists, Charlotte
Southeastern Medical Oncology Center (SMOC), Goldsboro
Regional Medical Oncology Center, Wilson

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06605404

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Duke Cancer Center Cary, Cary
Duke University Medical Center, Durham
Duke Cancer Center Raleigh, Raleigh

피험자 모집 중3상

75세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT07068074

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Carolina Biooncology Institute, Huntersville

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT05267626

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Wake Forest University at Clemmons, Clemmons
Southeastern Medical Oncology Center-Clinton, Clinton
Southeastern Medical Oncology Center-Goldsboro, Goldsboro
외 4개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT04511013

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

UNC- Chapel Hill, Chapel Hill

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT05059444

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

University of North Carolina, Chapel Hill

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07288112

Project: Every Child for Younger Patients With Cancer

Mission Hospital, Asheville
UNC Lineberger Comprehensive Cancer Center, Chapel Hill
Carolinas Medical Center/Levine Cancer Institute, Charlotte
외 4개

피험자 모집 중관찰 연구

25세 이하 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT02402244

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Lineberger Comprehensive Cancer Center, Chapel Hill

피험자 모집 중1상

18세 ~ 99세 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT03454035

Integrated Cancer Repository for Cancer Research

Cape Fear Valley Health System, Fayetteville

피험자 모집 중관찰 연구건강한 지원자 환영

19세 ~ 110세 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT02012699

A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel

UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill

피험자 모집 중1/2상

18세 ~ 70세 · 모든 성별 · 2026. 6. 15. 업데이트됨 · NCT06940739

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

Duke University Medical Center, Durham

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 6. 8. 업데이트됨 · NCT03947385

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

University of North Carolina at Chapel Hill, Chapel Hill

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 4. 28. 업데이트됨 · NCT06413680

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Duke University Medical Center, Durham

피험자 모집 중2/3상

전 연령 · 모든 성별 · 2026. 4. 2. 업데이트됨 · NCT06581406

A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

Carolina BioOncology Institute, Huntersville

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 1. 21. 업데이트됨 · NCT07317505

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

Duke University Medical Center - Duke Cancer Center, Durham

피험자 모집 중3상

18세 이상 · 모든 성별 · 2025. 12. 17. 업데이트됨 · NCT03567889

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Chapel Hill
Massive Bio SYNERGY-AI site, Winston-Salem

피험자 모집 중관찰 연구

전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

Excision of Lymph Node Trial (EXCILYNT) (Mel69)

Duke University Health System, Durham

피험자 모집 중

18세 이상 · 모든 성별 · 2025. 9. 17. 업데이트됨 · NCT05839912

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

University of North Carolina at Chapel Hill, Chapel Hill
Duke University Medical Center, Durham
East Carolina University, Greenville
외 1개

피험자 모집 중

18세 이상 · 모든 성별 · 2024. 11. 27. 업데이트됨 · NCT03860883

DermaSensor Postmarket Surveillance Study

West Clinical Research, Morehead City

피험자 모집 중

40세 이상 · 모든 성별 · 2024. 10. 31. 업데이트됨 · NCT06666790

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.